SEGMENT INFORMATION

9 Months Ended

Jun. 29, 2012

SEGMENT INFORMATION

17. SEGMENT INFORMATION

The Company’s operations are grouped into two reportable operating segments: Oncology Systems and X-ray Products. These reportable operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The Company’s Ginzton Technology Center, Security and Inspection Products business and Varian Particle Therapy business are reflected in the “Other” category because these operating segments do not meet the criteria of a reportable operating segment. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.

The following table summarizes selected operating results information for each business segment:

	Three Months Ended						Nine Months Ended
(In millions)	June 29, 2012			July 1, 2011			June 29, 2012			July 1, 2011
Revenues
Oncology Systems	$	546		$	513		$	1,599		$	1,473
X-ray Products		127			121			363			350
Total reportable segments	$	673		$	634		$	1,962		$	1,823
Other		32			16			89			55
Total company	$	705		$	650		$	2,051		$	1,878
Operating Earnings (Loss)
Oncology Systems	$	127		$	120		$	364		$	368
X-ray Products		35			30			94			88
Total reportable segments	$	162		$	150		$	458		$	456
Other		(8	)		(8	)		(27	)		(21	)
Corporate		0			(1	)		(5	)		(6	)
Total company	$	154		$	141		$	426		$	429